5151 - 5175 of 6324 Results
Title
Year
-
OPENTitle: A lipid switch unlocks Parkinson’s disease-associated ATP13A2Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 29Start Page: 9040End Page: 9045Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1508220112Best OA location URL: https://www.pnas.org/content/pnas/112/29/9040.full.pdfCitation Count: 91
-
OPENTitle: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neuronsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 1020End Page: 1048Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2021.1967615Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1967615?needAccess=trueCitation Count: 41
-
OPENTitle: Structural basis for feedforward control in the PINK1/Parkin pathwayJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2021109460Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2021109460Citation Count: 21
-
OPENTitle: Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00427-6Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-021-00427-6Citation Count: 341
-
OPENTitle: Cross‐Sectional and Prospective Associations between Parkinsonism and Parkinson's Disease with Frailty in Latin AmericaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14214Best OA location URL: https://escholarship.org/uc/item/9zr458xhCitation Count: 0
-
OPENTitle: Heat Shock Protein 70 as a Sex-Skewed Regulator of α-SynucleinopathyJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 2541End Page: 2564Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-021-01114-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01114-6.pdfCitation Count: 6
-
OPENTitle: Longitudinal assessment of excessive daytime sleepiness in early Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 88Issue #: 8Start Page: 653End Page: 662Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2016-315023Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7282477Citation Count: 100
- Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation2021OPENTitle: Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 3Start Page: 1038End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab371Best OA location URL: https://academic.oup.com/brain/article-pdf/145/3/1038/43499976/awab371.pdfCitation Count: 61
-
OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6429430Citation Count: 42
-
OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 52
-
OPENTitle: Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 12Start Page: 5765End Page: 5774Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1814909116Best OA location URL: https://www.pnas.org/content/pnas/116/12/5765.full.pdfCitation Count: 98
- α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons2018OPENTitle: α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neuronsJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-018-0537-xBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-018-0537-xCitation Count: 83
-
OPENTitle: Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6357Start Page: 1255End Page: 1261Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aam9080Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6021018Citation Count: 736
-
OPENTitle: MicroRNA Deregulation in Blood Serum Identifies Multiple System Atrophy Altered PathwaysJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 10Start Page: 1873End Page: 1879Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28143Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28143Citation Count: 16
- O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease2017OPENTitle: O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s diseaseJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-017-0311-1Best OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-017-0311-1Citation Count: 81
-
OPENTitle: Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 748End Page: 759Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30140-1Best OA location URL: https://kclpure.kcl.ac.uk/ws/files/113416685/MainText_Politis_RevisedManuscript_Clean.pdfCitation Count: 88
- The Amplification of Alpha‐Synuclein Amyloid Fibrils is Suppressed under Fully Quiescent Conditions2024OPENTitle: The Amplification of Alpha‐Synuclein Amyloid Fibrils is Suppressed under Fully Quiescent ConditionsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 64Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/anie.202419173Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11811685Citation Count: 3
- CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated Protein2024OPENTitle: CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated ProteinJournal Name: Journal of Chemical Information and ModelingPublisher: American Chemical Society (ACS)Vol: 64Issue #: 22Start Page: 8521End Page: 8536Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jcim.4c01267Best OA location URL: https://hal.science/hal-04773884Citation Count: 13
-
OPENTitle: Interplay between tau and α‐synuclein liquid–liquid phase separationJournal Name: Protein SciencePublisher: WileyVol: 30Issue #: 7Start Page: 1326End Page: 1336Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pro.4025Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.4025Citation Count: 83
-
OPENTitle: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320aJournal Name: Journal of NeuroimmunologyPublisher: Elsevier BVVol: 278Issue #:Start Page: 185End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4297694Citation Count: 64
-
OPENTitle: Feasibility of Virtual Research Visits in Fox Trial FinderJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 5Issue #: 3Start Page: 505End Page: 515Publication Date:Open Access(OA) Status: OPENLicense: unspecified-oaDOI - Digital Object Identifier: 10.3233/jpd-150549Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd150549?id=journal-of-parkinsons-disease%2Fjpd150549Citation Count: 61
-
OPENTitle: Understanding what aspects of Parkinson’s disease matter most to patients and familiesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-71555-4Best OA location URL: https://doi.org/10.1038/s41598-024-71555-4Citation Count: 8
-
OPENTitle: BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1053591Best OA location URL: https://doi.org/10.3389/fneur.2022.1053591Citation Count: 1
-
OPENTitle: Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological α-synucleinJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aba1193Best OA location URL: https://advances.sciencemag.org/content/advances/6/18/eaba1193.full.pdfCitation Count: 58
-
OPENTitle: Investigating the impact of Cu2+ on α-synuclein aggregation: A single-molecule approachJournal Name: International Journal of Biological MacromoleculesPublisher: Elsevier BVVol: 307Issue #:Start Page: 142161End Page: 142161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ijbiomac.2025.142161Best OA location URL: https://doi.org/10.1016/j.ijbiomac.2025.142161Citation Count: 0